Previous 10 | Next 10 |
BELGRADE, Mont., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT, the “Company”), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the closing of its previously announce...
Xtant Medical Holdings, Inc. (XTNT) Q4 2020 Earnings Conference Call Feb 24, 2020, 09:00 AM ET Company Participants Matt Steinberg - Lazar FINN Partners Sean Browne - President and CEO Greg Jensen - VP Finance and CFO Conference Call Participants Presentation Operator Greetings, and welcome t...
Xtant Medical (XTNT): Q4 GAAP EPS of -$0.01.Revenue of $14M (-17.5% Y/Y)Press Release For further details see: Xtant Medical reports Q4 results
BELGRADE, Mont., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the fourth quarter and year ende...
Xtant Medical Holdings ([[XTNT]] -0.9%) has entered into a definitive agreement for a private placement of ~8.89M common shares and warrants to purchase ~6.67M shares at a combined purchase price of $2.25 /share for gross proceeds of ~$20M.The warrants will have an exercise price of $2.25/sha...
BELGRADE, Mont., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT) (the Company), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced it has entered into a definitive agreement with a sin...
BELGRADE, Mont., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the fourth quarter a...
BELGRADE, Mont., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that the subscription period for its previously announced rights of...
Universal Security Instruments (UUU) +87%.Cellect Biotechnology (APOP) +36%.Pinterest (PINS) +31% on Q3 results.Inphi Corporation (IPHI) +27% as the company will be acquired by Marvell in a cash and stock transaction.Xtant Medical Holdings (XTNT) +22% on Q3 resul...
Xtant Medical (XTNT): Q3 GAAP EPS of -$0.10 beats by $0.01.Revenue of $14M (-10.9% Y/Y) misses by $2.04M.Press Release For further details see: Xtant Medical EPS beats by $0.01, misses on revenue
News, Short Squeeze, Breakout and More Instantly...
Xtant Medical Holdings Inc. Company Name:
XTNT Stock Symbol:
NYSE Market:
Xtant Medical Holdings Inc. Website:
BELGRADE, MT / ACCESSWIRE / July 25, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief ...
BELGRADE, MT / ACCESSWIRE / May 22, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief...
Expects Revenue for Full Year 2024 of $116 Million to $120 Million BELGRADE, MT / ACCESSWIRE / May 15, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial a...